Yahoo Web Search

Search results

1. • Rigel Reports First Quarter 2024 Financial Results and Provides Business Update

     Lodi News-Sentinel· 5 days ago

     First quarter 2024 total revenue of $29.5 million, which includes TAVALISSE® net product sales of $21.1 million and REZLIDHIA® net product sales of $4.9 millionExpanded Rigel's portfolio with acquisition of

2. • Kite and Arcellx Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program

     Morningstar· 3 days ago

     Kite, a Gilead Company (NASDAQ: GILD), and Arcellx, Inc. (NASDAQ: ACLX) today announced several key operational updates on their partnered anitocabtagene autoleucel (anito-cel) multiple myeloma ...

3. • Moleculin Announces U.S. Patent Issue Notification for Lipid-Based Delivery Technology for Annamycin

     NBC 17 Raleigh· 3 days ago

     Moleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin or the Company), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses ...

4. • AML/T cell interactomics uncover correlates of patient outcomes and the key role of ICAM1 in T cell...

     Nature· 3 days ago

     T cells are important for the control of acute myeloid leukemia (AML), a common and often deadly malignancy. We observed that some AML ...

5. • 

     TC BioPharm to acquire CAR-T therapy developer By Investing.com

     Investing.com· 6 days ago

     TC BioPharm (Holdings) PLC (NASDAQ: TCBP), a clinical-stage biopharmaceutical company, today...

6. • 

     To my late mom on Mother's Day: I miss you and hope you'd be proud | Anna Snyder

     The Tuscaloosa News· 4 days ago

     Anna Snyder's mom passed away nearly 2 years ago. Here is her love letter on Mother's Day to the...

7. • 

     Syndax Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Clinical and...

     WTNH-TV New Haven· 4 days ago

     Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an...

8. • Exxon hit with $725.5 million verdict over mechanic's leukemia diagnosis

     Reuters via Yahoo Finance· 2 days ago

     A Pennsylvania jury ordered ExxonMobil to pay $725.5 million to a former mechanic who claimed toxic chemicals in the company’s gasoline and solvents caused his cancer, according to attorneys ...

9. • 

     Regeneron's cell medicines chief is crafting a new cell therapy 'secret sauce'

     FierceBiotech· 3 days ago

     Phil Gregory’s new gig looks a whole lot like his old gig. It’s just that, under the umbrella of...

10. • GlycoMimetics (GLYC) to Release Earnings on Thursday

      ETF DAILY NEWS· 4 days ago

      GlycoMimetics (NASDAQ:GLYC – Get Free Report) will be announcing its earnings results before the market opens on Thursday, May 9th. Analysts expect the company to announce earnings of ($0.15 ...